Minimum Target Prices for Production of Direct-Acting Antivirals and Associated Diagnostics to Combat Hepatitis C Virus
File(s)vanderven.pdf (1.88 MB) hep27641.pdf (683.59 KB)
Accepted version
Published Version
Author(s)
Type
Journal Article
Date Issued
2015-02-09
Date Acceptance
2014-12-02
Citation
Hepatology, 2015, 61 (4), pp.1174-1182
ISSN
1527-3350
Publisher
Wiley
Start Page
1174
End Page
1182
Journal / Book Title
Hepatology
Volume
61
Issue
4
Copyright Statement
© 2014 The Authors. Hepatology published by Wiley Periodicals, Inc., on behalf of the American Association for the Study of Liver Diseases.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Subjects
Science & Technology
Life Sciences & Biomedicine
Gastroenterology & Hepatology
HCV CORE ANTIGEN
PROTEASE INHIBITOR
SOFOSBUVIR
INFECTION
ASSAY
DISCOVERY
MK-5172
COST
AG
Publication Status
Published